Smita Kumari, PhD

Citada per

	Totes	Des de 2020
Citacions	365	363
Índex h	9	9
Índex i10	9	9

180

135

2020202120222023202420257 24 50 90 162 28

Accés públic

Mostra-ho tot

3 articles

7 articles

disponibles

no disponibles

Es basa en els requisits de les agències que proporcionen el finançament

Coautors

Pravir KumarDean (International Affairs), Professor (Biotechnology), Delhi Technological UniversityCorreu electrònic verificat a dtu.ac.in
Rashmi K. Ambasta, PhDResearch Assistant Professor of Medicine, Vanderbilt University Medical CenterCorreu electrònic verificat a vumc.org
Dr. Rohan Gupta, Ph.D.GMDRC, Galgotias University, Greater Noida, U.PCorreu electrònic verificat a galgotiasuniversity.edu.in
Dia Advani, PhDCentre for Applied and Translational Genomics, MBRU, Dubai healthCorreu electrònic verificat a dubaihealth.ae
Nimish GuptaStaff Engineer, Regeneron PharmaceuticalsCorreu electrònic verificat a regeneron.com
Swadhin K. MandalIISER KolkataCorreu electrònic verificat a iiserkol.ac.in
Aniruddha SenguptaSPARCCorreu electrònic verificat a sparcmail.com
Sanghamitra MylavarapuCorreu electrònic verificat a rcb.res.in
Gaurao V. DhokeSyngene International Limited Bangalore IndiaCorreu electrònic verificat a biotec.rwth-aachen.de
Sudip RoyPrescience Insilico Private LimitedCorreu electrònic verificat a prescience.in
Vishal RaiAssociate Professor, Chemistry, IISER BhopalCorreu electrònic verificat a iiserb.ac.in
Goutam BiswasCooch Behar Panchanan Barma UniversityCorreu electrònic verificat a cbpbu.ac.in
Harsh KumarSt. Jude Children's Research Hospital, Memphis TN USACorreu electrònic verificat a stjude.org
Dr. Sivaram V S MylavarapuProfessor of Biotechnology, Regional Centre for Biotechnology, Faridabad IndiaCorreu electrònic verificat a rcb.res.in
Sujit SarkarInvictus Oncology Pvt. Ltd.Correu electrònic verificat a invictusoncology.com
Arindam SarkarFaculty, India Innovation Research CenterCorreu electrònic verificat a indiainnovationcenter.org

Segueix

Smita Kumari, PhD

The Ohio State University

Correu electrònic verificat a osu.edu

Cancer biology Neuro-oncology Tumor microenvironment Computational Biology Translation research


Títol Ordena per cites Ordena per any Ordena per títol	Citada per Citada per	Any
Combinatorial therapy in tumor microenvironment: where do we stand? S Kumari, D Advani, S Sharma, RK Ambasta, P Kumar Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1876 (2), 188585, 2021	91	2021
New era of artificial intelligence and machine learning-based detection, diagnosis, and therapeutics in Parkinson’s disease R Gupta, S Kumari, A Senapati, RK Ambasta, P Kumar Ageing research reviews, 102013, 2023	74	2023
Unboxing the molecular modalities of mutagens in cancer S Kumari, S Sharma, D Advani, A Khosla, P Kumar, RK Ambasta Environmental Science and Pollution Research, 1-49, 2021	59	2021
Computationally designed antibody–drug conjugates self-assembled via affinity ligands N Gupta, A Ansari, GV Dhoke, M Chilamari, J Sivaccumar, S Kumari, ... Nature biomedical engineering 3 (11), 917-929, 2019	28	2019
Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy S Kumari, R Gupta, RK Ambasta, P Kumar Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1878 (4), 188913, 2023	26	2023
Precision oncology, signaling, and anticancer agents in cancer therapeutics D Advani, S Sharma, S Kumari, RK Ambasta, P Kumar Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022	25	2022
Activation of epithelial-mesenchymal transition and altered β-catenin signaling in a novel Indian colorectal carcinoma cell line S Mylavarapu, H Kumar, S Kumari, LS Sravanthi, M Jain, A Basu, ... Frontiers in Oncology 9, 54, 2019	18	2019
Unwinding the modalities of necrosome activation and necroptosis machinery in neurological diseases R Gupta, S Kumari, R Tripathi, RK Ambasta, P Kumar Ageing Research Reviews 86, 101855, 2023	12	2023
A safe and efficacious Pt (ii) anticancer prodrug: design, synthesis, in vitro efficacy, the role of carrier ligands and in vivo tumour growth inhibition PK Dutta, R Sharma, S Kumari, RD Dubey, S Sarkar, J Paulraj, ... Chemical Communications 55 (12), 1718-1721, 2019	11	2019
Design and computational analysis of an MMP9 inhibitor in hypoxia-induced glioblastoma multiforme S Kumari, P Kumar ACS omega 8 (11), 10565-10590, 2023	9	2023
Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme S Kumari, R Gupta, RK Ambasta, P Kumar Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1878 (6), 188999, 2023	5	2023
Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment S Kumari, P Kumar Frontiers in Cell and Developmental Biology 11, 2023	4	2023
IO-125: A novel supramolecular platinum chemotherapy for triple negative breast cancer. A Sengupta, S Mylavarapu, S Kumari, S Hossain, N Gupta, A Sarkar, ... Journal of Clinical Oncology 33 (28_suppl), 153-153, 2015	2	2015
Phenalenyl based platinum anticancer compounds with superior efficacy: design, synthesis, characterization, and interaction with nuclear DNA P Dutta, S Kumari, J Paulraj, R Sharma, G Vijaykumar, HS Das, ... New Journal of Chemistry 45 (23), 10524-10533, 2021	1	2021

En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.

Articles 1–14

Cites per any

Cites duplicades

Cites combinades

Addició de coautorsCoautors

Segueix

Citada per

Coautors